101 J Morris Commons Ln. Headquarters Research Triangle Park, NC (US) Size 1001 to 5000 employees. We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. The project is part of Fujifilm’s JPY10bn ($90m) investment plan announced in January 2019 to expand its biotechnology CDMO business. Diosynth, or Fujifilm Diosynth Biotechnologies (FDB), is a company that develops and offers manufacturing processes for active ingredients for pharmaceutical companies.. History. He joined FDB in 2011 at RTP, North Carolina. College Station, TX. Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…, Arranta Bio is constructing a new multi-product, commercial-ready manufacturing facility in Watertown, Massachusetts, US. The bioreactors can function in batch, fed-batch and perfusion bioreactor modes depending upon the requirement. Photographic Film and Paper, Film Cameras, Digital Cameras, Photofinishing Products, Graphic Systems, Medical Systems, Motion Picture Products, Recording Media. United States. Headquarters functions of FUJIFILM Holdings Corporation, FUJIFILM Corporation, and Fuji Xerox Co., Ltd. relocated to the Tokyo Midtown Building: July: Established FUJIFILM Business Expert Corporation and concentrated the administrative and human resource operations: 2008 Jan. Acquired Germany-based IP Labs GmbH, a developer of online photo service systems Senior Director, Corporate Office Keita Hirabayashi is responsible for FUJIFILM Corporation’s 80% interest in FUJIFILM Diosynth Biotechnologies and supporting the executive management team. Besides the BioProcess Innovation Center in North Carolina, the company is also located in College Station, Texas, US, as well as Billingham and Redcar in the UK. News from Tokyo Headquarters Nov 30, 2020. The company is a contract development and manufacturing organisation (CDMO) subsidiary of Fujifilm Holdings. As we continue to grow, we look for qualified candidates for a variety of administrative, business, manufacturing, technical, and scientific career opportunities. We are actively involved with many of the major industry organizations and professional associations. Fujifilm Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organization with locations in Research Triangle Park, North Carolina and Billingham, United Kingdom. Fujifilm Diosynth Biotechnologies is expanding its existing BioProcess Innovation Center in North Carolina, US. It will also add cell culture purification capabilities and new microbial recovery capabilities to the facility. FUJIFILM Diosynth Biotechnologies is proud of its history of strong and productive partnerships. The company began preparations for the…, Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The pAVEway™ system is based on unique modified E.coli vectors for high-level expression of proteins. Fujifilm Diosynth Biotechnologies has now completed a $93 million Texas manufacturing facility it acquired several years ago, the company announced … Meeson is currently the president and COO of its U.S. subsidiary, Fujifilm Diosynth Biotechnologies, U.S.A. – which calls Morrisville the home of its headquarters. It aims for the business to achieve a sales target of JPY100bn ($919.4m) by March 2024. This field is for validation purposes and should be left unchanged. The company manufactures, markets and provides service for a broad spectrum of industries including photographic, medical imaging and informatics, pharmaceutical, regenerative medicine, and biopharmaceutical contract manufacturing. Below is a calendar of upcoming conferences and events. Watertown facility will be used for…, Berkshire Sterile Manufacturing (BSM) is expanding its manufacturing facility in Lee, Massachusetts (MA), US. BILLINGHAM, UK, August 17,2020 – FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announce today that its site in Billingham, UK will manufacture antigen component of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. Novavax has taken over three floors of lab space in the facility to expedite its vaccine research and development process. 3939 Biomedical Way College Station, TX 77845 United States of America +1 979 431 3500, Biogen Allé 1 3400 Hillerød Denmark +45 7741 6000, 101 J Morris Commons Lane Morrisville, NC 27560 United States of America +1 919 337 4400, Belasis Avenue Billingham, TS23 1LH United Kingdom +44 1642 363511. The project will improve the facility’s manufacturing capacity for cell cultures by 25% and microbial systems by 50%. in Latin America, the Middle East, Africa, Eastern Europe and Asia-Pacific) are conducted primarily through subsidiaries and account for 54-57% of the company’s sales. Fujifilm Diosynth Biotechnologies headquarters is located at 101 J Morris Commons Ln, Morrisville. GE Healthcare’s Xcellerex single-use bioreactors installed at the facility are beneficial for biologics production due to low capital requirement, operational cost and environmental footprint. Biotechnology + Life Sciences. Marketing commentary on Fujifilm Diosynth Biotechnologies. He takes over as the Japanese CDMO is in the midst of an infrastructure expansion in the U.S. Details of Fujifilm Diosynth Biotechnologies’ Existing Biomanufacturing Facility Spanning approximately 7,000 acres, the Research Triangle Park is situated close to the cities of Raleigh, Durham and Chapel Hill. Fujifilm Diosynth Biotechnologies develops and manufactures recombinant proteins, monoclonal antibodies (mAb), vaccines and other types of molecules expressed in mammalian and microbial systems. The FUJIFILM Diosynth Biotechnologies’ Bioprocess Innovation Center made national news recently when the president visited the facility to witness firsthand some of the most cutting-edge research on vaccines for COVID-19. Our focus is to combine technical leadership in cell culture, microbial fermentation and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines. The North Carolina facility includes Fujifilm’s process, analytical R&D unit and the process sciences and stability unit. Fujifilm Diosynth Biotechnologies (FDB) broke ground to signal the start of its expansion project on its North Carolina facility for cell culture and microbial capacity. Fujifilm Diosynth Biotechnologies has extensive experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal … Manager Corporate Office Fujifilm Diosynth Biotechnologies (formerly Merck BioManufacturing Network) 2011 – Present 8 years. FUJIFILM Diosynth Biotechnologies is a leading contract development and manufacturing organization (CDMO) providing process development and manufacturing of biologics at four locations: Search here for articles and publications that mention the business activities of FUJIFILM Diosynth Biotechnologies or feature our scientists and executive leadership in interviews or profiles. As a CDMO our focus is to combine technical leadership in cell culture, microbial fermentation and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines. The facility is equipped with a 2,000l stainless steel train, a seed train and purification equipment, which are in line with the company’s hybrid implementation approach. It currently houses 200l and 1,000l GE Healthcare Xcellerex single-use bioreactors along with single-use mixers and single-use harvest filtration equipment. Fujifilm Diosynth Biotechnologies is a leader in contract process development with a proven record in clinical & commercial cGMP contract manufacturing of complex recombinant proteins, vaccines, antibody derivatives, enzymes and fusion proteins. 94-468 Akoki Street, Waipahu, Hawaii 96797, U.S.A. Website. The expansion project is expected to meet Fujifilm’s target and strengthen its CDMO business as well as serve the growing requirements of its broad customers’ base. FUJIFILM Holdings America Corporation is the regional headquarters for the Americas. Throughout the year, FUJIFILM Diosynth Biotechnologies participates in a variety of trade shows, industry conferences, scientific meetings and symposiums, and other events. Our focus is to combine technical leadership in cell culture, microbial fermentation and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines. Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne, Thermo Fisher’s Biologics and Sterile Drug Manufacturing Facility, Hangzhou, Arranta’s New Commercial-Ready Manufacturing Facility, Watertown, Massachusetts, Special delivery: the logistics of curing Covid-19, The Chancellor’s Spending Review: transforming the UK into a ‘scientific superpower‘, The rise of gout: examining drug development for an age-old disease, Implementing the ballroom concept for biomanufacturing: Lessons, reflections and considerations from experience, BioMarin and Deep Genomics team up on AI rare disease drug discovery, Berkshire Sterile Manufacturing Facility Expansion, Lee, Massachusetts, Lykan Bioscience’s SMART Manufacturing Facility, Hopkinton, Massachusetts. The expansion will add 2,000l single-use cell culture manufacturing trains to the state-of-the-art three-storey, 62,000ft² North Carolina facility. At the end of 2017, Merck & Co had approximately69,000 employees internationally. Address. Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. About 39% of their workforce is located in the United States (including Puerto Rico). News from Tokyo Headquarters Nov 25, 2020. Founded Unknown. Fujifilm Diosynth Biotechnologies U.s.a.'s annual revenues are over $500 million (see exact revenue data) and has 500-1,000 employees. Services include cell line development, process and analytical development, clinical and commercial manufacturing and bioprocess research and development. The company started in Oss, Netherlands in 1923 with the extraction of insulin from bovine pancreas, and porcine insulin extraction in 1930, both of which are still part of their main products. FUJIFILM Diosynth Biotechnologies is led by a seasoned team of executives.Their cumulative knowledge and combined professional backgrounds add up to unparalleled leadership that keeps our organization a step ahead of the industry and in sync with our customers’ needs. Type Subsidiary or Business Segment. FUJIFILM Diosynth Biotechnologies is a CDMO partner for life. Fujifilm Diosynth Biotechnologies has offices in Morrisville, College Station, Miami, Hillerød and in 1 other location. The park is one of the biggest research and science parks in the US. For over 30 years our focus has been on supporting our customers with the development and manufacture of recombinant proteins, viral vaccines and gene therapies. Fujifilm develops the new “Pixel Shift Multi-Shot” function to capture and generate the world’s highest resolution of 400MP images with accurate color reproduction ... FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income Countries. All Fujifilm Diosynth Biotechnologies Locations. The project is scheduled to be completed by early 2020. Fujifilm Diosynth Biotechnologies Table 113 Fujifilm Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organization with locations in USA and UK. This gives us an opportunity to forge relationships with respected researchers, engineers and scientists from around the globe. Merck & Co’s operations outside the United States (e.g. We offer a work environment that promotes individual responsibility and growth, a collaborative spirit, and an atmosphere that encourages learning and professional development. The authority stumped up £1.2m to raze the 10-storey former ICI headquarters before Fujifilm Diosynth bought the land in 2014 for its expansion project. Pharmaceutical sales for Merck in 2017 amounted to $35.4 billion USD (including animal health products: $40.1B). Press release 2020-10-08, Press release 2020-10-07, Press release 2020-08-19, Process development for successful gene therapies, Analytical development for gene therapy and viral vaccines, Gene therapy and viral products cGMP production, Research Triangle Park, North Carolina, USA. Morrisville (HQ), NC. Fujifilm Holdings Corporation (富士フイルム株式会社, Fujifuirumu Kabushiki-kaisha), trading as Fujifilm, or simply Fuji, is a Japanese multinational photography, imaging, printing, medical equipment, chemical, biotechnology company headquartered in Tokyo, Japan . Create Comparison. It also features a mammalian expression platform called Apollo™, which helps increase the productivity and speed of commercial manufacturing. World WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir No drug based on monoclonal antibodies has yet been approved against COVID-19, but the WHO scheme has already invested in research on the new technology and has secured production capacity at a plant of Fujifilm Diosynth Biotechnologies in Denmark. FILE PHOTO: Fujifilm's company logo (top) is seen at its exhibition hall nearby the headquarters of Fujifilm Holdings Corp in Tokyo, Japan June 12, 2017. News Release Corporate & Brand CDMO Pharmaceuticals Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals. Fujifilm Diosynth Biotechnologies has named a new CEO, but he is an old hand at the company. Manager Corporate Office FUJIFILM Diosynth … It was developed by a collaboration of universities, companies and the government to support research and development (R&D) in North Carolina. It is comprised of 21 affiliate companies across North and Latin America. The…, Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here, “The platform complements the company’s pAVEway™ microbial system, which is utilised for efficient microbial protein expression.”. Fujifilm Diosynth Biotechnologies provides biologics contract development and manufacturing. The single-use bioreactors are stirred tank bioreactors for scalable and robust performance in both current good manufacturing practice (cGMP) and non-cGMP conditions. To be the leading and most trusted global Contract Development and Manufacturing Organization in the biopharmaceutical industry. Fujifilm’s biomanufacturing facility is located in the Research Triangle Park in North Carolina, close to Morrisville and Cary communities. Miami, FL. The platform complements the company’s pAVEway™ microbial system, which is utilised for efficient microbial protein expression. FUJIFILM Diosynth Biotechnologies is a CDMO partner for life. August 17, 2020. The bioreactors are suitable for multi-product contract manufacturing with the advantage of easy expansion to meet increased demand and can flexibly manufacture products for pre-clinical and clinical studies. FUJIFILM Holdings adopts “Fujifilm Group AI Policy” (FUJIFILM Holdings) ... FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to manufacture COVID-19 Vaccine Candidate at its Billingham site. … FUJIFILM Diosynth Biotechnologies is an industry-leading Biologics Contract Development and Manufacturing Organization (CDMO) with locations in Teesside, UK, RTP, North Carolina, College Station, Texas and Hillerød, Denmark. The … Where are Fujifilm Diosynth Biotechnologies offices? 3939 Bio-Medical Way. The Apollo™ platform consists of a CHO DG44-derived host cell line, a new expression vector, a cell line development process that uses state-of-the-art screening technologies, and media and feed components. Unknown. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry. ... FUJIFILM Diosynth Biotechnologies 305. United States.